“In the US, May is celebrated as National Osteoporosis Awareness and
Prevention month. Such initiatives are increasing the awareness of bone
health among the general population”

According to the new report, enhanced patient and physician awareness
has been leading to greater drug penetration. Additionally, institutions
like the National Osteoporosis Foundation are dedicated to the
prevention of osteoporosis and fractures.

“In the US, May is celebrated as National Osteoporosis Awareness and
Prevention month. Such initiatives are increasing the awareness of bone
health among the general population,” says Faisal Ghaus, Vice President
of TechNavio.

Furthermore, the paradigm shift from antiresorptive therapies to
anabolic drugs is also expected to propel the overall market growth.
Treatments for osteoporosis, which haven’t evolved much in the past 20
years, will see a major overhaul with the launch of new efficacious and
safe anabolic treatments.

“Three late-stage pipeline products, romosozumab, BA-058 and oral PTH
have been found to be highly effective in increasing bone mineral
density (BMD) by almost double the amount as compared to current
treatment options,” says Ghaus.